ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Group B Streptococcus (GBS) Infection Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-12Y12555
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Group B Streptococcus GBS Infection Treatment Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Group B Streptococcus (GBS) Infection Treatment Market Research Report 2025

Code: QYRE-Auto-12Y12555
Report
June 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline PLC

Group B Streptococcus (GBS) Infection Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Group B Streptococcus (GBS) Infection Treatment Market

Group B Streptococcus (GBS) Infection Treatment Market

The global market for Group B Streptococcus (GBS) Infection Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Group B Streptococcus (GBS) Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Group B Streptococcus (GBS) Infection Treatment.
The Group B Streptococcus (GBS) Infection Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Group B Streptococcus (GBS) Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Group B Streptococcus (GBS) Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Group B Streptococcus (GBS) Infection Treatment Market Report

Report Metric Details
Report Name Group B Streptococcus (GBS) Infection Treatment Market
CAGR 5%
Segment by Type
  • Prenatal-onset Gbs Disease
  • Early-onset Gbs Disease
  • Late-onset Gbs Disease
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis, GlaxoSmithKline
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Group B Streptococcus (GBS) Infection Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Group B Streptococcus (GBS) Infection Treatment Market report?

Ans: The main players in the Group B Streptococcus (GBS) Infection Treatment Market are Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis, GlaxoSmithKline

What are the Application segmentation covered in the Group B Streptococcus (GBS) Infection Treatment Market report?

Ans: The Applications covered in the Group B Streptococcus (GBS) Infection Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Group B Streptococcus (GBS) Infection Treatment Market report?

Ans: The Types covered in the Group B Streptococcus (GBS) Infection Treatment Market report are Prenatal-onset Gbs Disease, Early-onset Gbs Disease, Late-onset Gbs Disease

Recommended Reports

Infectious Disease Drugs

Infection Diagnostics

Other Bacterial Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prenatal-onset Gbs Disease
1.2.3 Early-onset Gbs Disease
1.2.4 Late-onset Gbs Disease
1.3 Market by Application
1.3.1 Global Group B Streptococcus (GBS) Infection Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Perspective (2020-2031)
2.2 Global Group B Streptococcus (GBS) Infection Treatment Growth Trends by Region
2.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Region (2020-2025)
2.2.3 Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2026-2031)
2.3 Group B Streptococcus (GBS) Infection Treatment Market Dynamics
2.3.1 Group B Streptococcus (GBS) Infection Treatment Industry Trends
2.3.2 Group B Streptococcus (GBS) Infection Treatment Market Drivers
2.3.3 Group B Streptococcus (GBS) Infection Treatment Market Challenges
2.3.4 Group B Streptococcus (GBS) Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Revenue
3.1.1 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Revenue (2020-2025)
3.1.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Group B Streptococcus (GBS) Infection Treatment Revenue
3.4 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
3.4.1 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Group B Streptococcus (GBS) Infection Treatment Revenue in 2024
3.5 Global Key Players of Group B Streptococcus (GBS) Infection Treatment Head office and Area Served
3.6 Global Key Players of Group B Streptococcus (GBS) Infection Treatment, Product and Application
3.7 Global Key Players of Group B Streptococcus (GBS) Infection Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Type
4.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Type (2020-2025)
4.2 Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2026-2031)
5 Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Application
5.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2020-2025)
5.2 Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Group B Streptococcus (GBS) Infection Treatment Market Size (2020-2031)
6.2 North America Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025)
6.4 North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Group B Streptococcus (GBS) Infection Treatment Market Size (2020-2031)
7.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025)
7.4 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size (2020-2031)
8.2 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size (2020-2031)
9.2 Latin America Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025)
9.4 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size (2020-2031)
10.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Alopexx Enterprises, LLC
11.2.1 Alopexx Enterprises, LLC Company Details
11.2.2 Alopexx Enterprises, LLC Business Overview
11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Introduction
11.2.4 Alopexx Enterprises, LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.2.5 Alopexx Enterprises, LLC Recent Development
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Details
11.3.2 Wellstat Vaccines LLC Business Overview
11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Introduction
11.3.4 Wellstat Vaccines LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.3.5 Wellstat Vaccines LLC Recent Development
11.4 Minervax ApS
11.4.1 Minervax ApS Company Details
11.4.2 Minervax ApS Business Overview
11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Introduction
11.4.4 Minervax ApS Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.4.5 Minervax ApS Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Introduction
11.5.4 Novartis Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline PLC
List of Tables
 Table 1. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prenatal-onset Gbs Disease
 Table 3. Key Players of Early-onset Gbs Disease
 Table 4. Key Players of Late-onset Gbs Disease
 Table 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2020-2025)
 Table 9. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2026-2031)
 Table 11. Group B Streptococcus (GBS) Infection Treatment Market Trends
 Table 12. Group B Streptococcus (GBS) Infection Treatment Market Drivers
 Table 13. Group B Streptococcus (GBS) Infection Treatment Market Challenges
 Table 14. Group B Streptococcus (GBS) Infection Treatment Market Restraints
 Table 15. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Group B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2024)
 Table 18. Ranking of Global Top Group B Streptococcus (GBS) Infection Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Group B Streptococcus (GBS) Infection Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Group B Streptococcus (GBS) Infection Treatment, Product and Application
 Table 22. Global Key Players of Group B Streptococcus (GBS) Infection Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Inc. Company Details
 Table 48. Pfizer Inc. Business Overview
 Table 49. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product
 Table 50. Pfizer Inc. Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Inc. Recent Development
 Table 52. Alopexx Enterprises, LLC Company Details
 Table 53. Alopexx Enterprises, LLC Business Overview
 Table 54. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product
 Table 55. Alopexx Enterprises, LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 56. Alopexx Enterprises, LLC Recent Development
 Table 57. Wellstat Vaccines LLC Company Details
 Table 58. Wellstat Vaccines LLC Business Overview
 Table 59. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product
 Table 60. Wellstat Vaccines LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 61. Wellstat Vaccines LLC Recent Development
 Table 62. Minervax ApS Company Details
 Table 63. Minervax ApS Business Overview
 Table 64. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product
 Table 65. Minervax ApS Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 66. Minervax ApS Recent Development
 Table 67. Novartis Company Details
 Table 68. Novartis Business Overview
 Table 69. Novartis Group B Streptococcus (GBS) Infection Treatment Product
 Table 70. Novartis Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 71. Novartis Recent Development
 Table 72. GlaxoSmithKline Company Details
 Table 73. GlaxoSmithKline Business Overview
 Table 74. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product
 Table 75. GlaxoSmithKline Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025) & (US$ Million)
 Table 76. GlaxoSmithKline Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources
 Table 80. Authors List of This Report


List of Figures
 Figure 1. Group B Streptococcus (GBS) Infection Treatment Picture
 Figure 2. Global Group B Streptococcus (GBS) Infection Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Prenatal-onset Gbs Disease Features
 Figure 5. Early-onset Gbs Disease Features
 Figure 6. Late-onset Gbs Disease Features
 Figure 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Pharmacies Case Studies
 Figure 10. Retail Pharmacies Case Studies
 Figure 11. Online Pharmacies Case Studies
 Figure 12. Group B Streptococcus (GBS) Infection Treatment Report Years Considered
 Figure 13. Global Group B Streptococcus (GBS) Infection Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Group B Streptococcus (GBS) Infection Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Players in 2024
 Figure 17. Global Top Group B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2024
 Figure 19. North America Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2020-2031)
 Figure 21. United States Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2020-2031)
 Figure 33. China Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Inc. Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 49. Alopexx Enterprises, LLC Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 50. Wellstat Vaccines LLC Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 51. Minervax ApS Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 52. Novartis Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 53. GlaxoSmithKline Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

B Streptococcus GBS Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Skin and Soft Tissue Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Streptococcus Group B Antibodies Market Research Report 2024
GAS Pharyngitis Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Myocarditis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coxsackievirus Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaginitis Therapeutics Market Insights Forecast to 2030
Intra abdominal Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rhinovirus Infections Drug Market Research Report 2024
Infectious Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Global Gravid Treatment Market Research Report 2024
Global GP Vaccination Market Research Report 2025
Biofilms Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multisystem Inflammatory Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Infection Diagnostic Market Research Report 2024
Global Bronchitis Treatment Drug Market Research Report 2025

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions